Cargando…

Meta-Analysis of Clinical Efficacy and Safety of Ligustrazine in the Treatment of Idiopathic Pulmonary Fibrosis

OBJECTIVE: To systematically review the efficacy and safety of Ligustrazine in the treatment of idiopathic pulmonary fibrosis (IPF). METHODS: The electronic literature databases (PubMed, EMbase, CNKI, WanFang database, and VIP) were retrieved through a computer to find out the randomized controlled...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Xiaozheng, Li, Wen, Luo, Zhenliang, Chen, Yunzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665923/ https://www.ncbi.nlm.nih.gov/pubmed/33204284 http://dx.doi.org/10.1155/2020/2416132

Ejemplares similares

The minor T allele of the MUC5B promoter rs35705950 associated with susceptibility to idiopathic pulmonary fibrosis: a meta-analysis
por: Wu, Xiaozheng, et al.
Publicado: (2021)

The molecular mechanism of Ligusticum wallichii for improving idiopathic pulmonary fibrosis: A network pharmacology and molecular docking study
por: Wu, Xiaozheng, et al.
Publicado: (2022)

Increased frequency of angiotensin converting enzyme D allele in Chinese Han patients with idiopathic pulmonary fibrosis: A systematic review and meta-analysis
por: Wu, Xiaozheng, et al.
Publicado: (2022)

Comparison of 4 kinds of traditional Chinese medicine injections to assist in improving clinical indicators of patients with idiopathic pulmonary fibrosis: A systematic review and network meta-analysis
por: Wu, Xiaozheng, et al.
Publicado: (2022)

Meta-Analysis of the Clinical Effectiveness and Safety of Ligustrazine in Cerebral Infarction
por: Yu, Tian, et al.
Publicado: (2016)

Traditional Chinese medicine as an adjunctive therapy for mild and common COVID-19: A systematic review and network meta-analysis
por: Wu, Xiaozheng, et al.
Publicado: (2021)

Efficacy and Safety of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis: An Update
por: Rodríguez-Portal, José Antonio
Publicado: (2017)

Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
por: Takeda, Yoshito, et al.
Publicado: (2014)

The Clinical Efficacy of Phytochemical Medicines Containing Tanshinol and Ligustrazine in the Treatment of Stable Angina: A Systematic Review and Meta-Analysis
por: Gao, Li, et al.
Publicado: (2021)

Efficacy and Safety of Traditional Chinese Medicine in Idiopathic Pulmonary Fibrosis: A Meta-Analysis
por: Ji, Kun, et al.
Publicado: (2020)

Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis
por: Yoon, Hee-Young, et al.
Publicado: (2018)

Ligustrazine Injection for Chronic Pulmonary Heart Disease: A Systematic Review and Meta-Analysis
por: Jian-sheng, Li, et al.
Publicado: (2012)

Efficacy and safety of N-acetylcysteine therapy for idiopathic pulmonary fibrosis: An updated systematic review and meta-analysis
por: Feng, Fanchao, et al.
Publicado: (2019)

Model‐based Meta‐Analysis on the Efficacy of Pharmacological Treatments for Idiopathic Pulmonary Fibrosis
por: Chan, Phyllis, et al.
Publicado: (2017)

Efficacy and safety of pirfenidone in the treatment of idiopathic pulmonary fibrosis patients: a systematic review and meta-analysis of randomised controlled trials
por: Wu, Wenjuan, et al.
Publicado: (2021)

Updated Evaluation of the Safety, Efficacy and Tolerability of Pirfenidone in the Treatment of Idiopathic Pulmonary Fibrosis
por: Gulati, Swati, et al.
Publicado: (2020)

Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis
por: Richeldi, Luca, et al.
Publicado: (2020)

Efficacy of Ligustrazine Injection as Adjunctive Therapy for Angina Pectoris: A Systematic Review and Meta-Analysis
por: Shao, Huikai, et al.
Publicado: (2015)

Meta-Analysis of Preventive and Therapeutic Effects of Ligustrazine on Airway Remodeling in Asthmatic Rats
por: Hua, Yu-shuang, et al.
Publicado: (2022)

The effects and safety of pirfenidone in the treatment of idiopathic pulmonary fibrosis: a meta-analysis and systematic review
por: Zang, Chenchen, et al.
Publicado: (2021)

Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
por: Sugino, Keishi, et al.
Publicado: (2021)

Ligustrazine for the Treatment of Unstable Angina: A Meta-Analysis of 16 Randomized Controlled Trials
por: Cao, Suman, et al.
Publicado: (2016)

Treatment of idiopathic pulmonary fibrosis: a network meta-analysis
por: Rochwerg, Bram, et al.
Publicado: (2016)

Efficacy and safety of the injection of the traditional Chinese medicine salviae miltiorrhizae and ligustrazine hydrochloride for the treatment of perioperative period of fracture: A meta-analysis of randomized controlled trials
por: Xie, Jialong, et al.
Publicado: (2020)

Combination of Salvia miltiorrhiza and ligustrazine attenuates bleomycin-induced pulmonary fibrosis in rats via modulating TNF-α and TGF-β
por: Huang, Chengliang, et al.
Publicado: (2018)

Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis
por: Flaherty, Kevin R., et al.
Publicado: (2018)

Efficacy of antioxidant in idiopathic pulmonary fibrosis: A systematic review and meta-analysis
por: Kandhare, Amit D., et al.
Publicado: (2016)

Pharmacokinetic study on the effect of ligustrazine–tangeretin co‐administration on the pharmacokinetics of ligustrazine and its potential mechanism in rats
por: Liu, Dandan, et al.
Publicado: (2023)

Analysis of the safety and efficacy of different plasma concentrations of pirfenidone in patients with idiopathic pulmonary fibrosis
por: Li, Hui, et al.
Publicado: (2022)

The Efficacy and Safety of Long-term Pirfenidone Therapy in Patients with Idiopathic Pulmonary Fibrosis
por: Ogawa, Kazumasa, et al.
Publicado: (2018)

Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practice
por: Fletcher, Sophie V., et al.
Publicado: (2018)

The Efficacy of Pulmonary Rehabilitation in Patients with Idiopathic Pulmonary Fibrosis
por: Choi, Hee Eun, et al.
Publicado: (2023)

Efficacy of leflunomide combined with ligustrazine in the treatment of rheumatoid arthritis: prediction with network pharmacology and validation in a clinical trial
por: Zhang, Chi, et al.
Publicado: (2019)

The treatment of idiopathic pulmonary fibrosis
por: Woodcock, Hannah V., et al.
Publicado: (2014)

Treatment of Idiopathic Pulmonary Fibrosis
por: Abuserewa, Sherif T, et al.
Publicado: (2021)

Efficacy of Ligustrazine Injection as Adjunctive Therapy in Treating Acute Cerebral Infarction: A Systematic Review and Meta-Analysis
por: Shao, Huikai, et al.
Publicado: (2021)

Treatment of pulmonary hypertension in idiopathic pulmonary fibrosis: shortfall in efficacy or trial design?
por: Nathan, Steven D, et al.
Publicado: (2014)

Efficacy of N-Acetylcysteine in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis
por: Sun, Tong, et al.
Publicado: (2016)

The Clinical Efficacy of Pulmonary Hypertension-Specific Agents in Idiopathic Pulmonary Fibrosis: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
por: Lee, Jonghoo, et al.
Publicado: (2020)

Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities
por: Glaspole, Ian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3fcloo09tnfufv04jj6egqff37